摘要
目的观察博尔宁辅助治疗癌性疼痛的临床疗效。方法将126例晚期癌症患者随机分为2组,观察组68例,应用硫酸吗啡缓释片同时加用博尔宁胶囊;对照组58例,单用硫酸吗啡缓释片,对比两组的临床疗效。结果观察组、对照组的疼痛完全缓解率分别为82.3%(56/68)、55.1%(32/58),两组比较,差异有统计学意义(P<0.01)。两组患者用药后不良反应比较,在恶心呕吐、便秘、出汗及头晕嗜睡方面,差异有统计学意义(P<0.01)。结论博尔宁配合硫酸吗啡缓释片镇痛效果确切,二者可以起到协同作用,同时减轻吗啡副作用,是辅助治疗癌性疼痛的理想药物。
Objective To observe the efficacy of adjuvant treatment of Boerning capsules on cancer pain.Methods 126 patients with advanced cancer were randomly divided into two groups: observe group(68 patients) were received Boerning capsules plus morphine sulfate sustained-release tablets,and control group(58 patients) were received morphine sulfate sustained-release tablets only.Clinical efficacy of the two groups were compared.Results There was significant difference in pain relief rates in observe group 82.3%(56/68) and control group 55.1%(32/58)(P0.01).And the adverse reactions such as queasiness,vomit,constipation,sweat,drowsiness and dizziness etc.in two groups were also compared(P0.01).Conclusion The analgesic effect of Boerning capsules plus morphine sulfate sustained-release tablets is exact,and the adjuvant theropy of Boerning can ameliorate the adverse reactions induced by morphine sulfate sustained-release tablets.Boerning is the ideal drug for adjuvant treatment of cnacer pain.
出处
《中国医药指南》
2013年第1期62-62,65,共2页
Guide of China Medicine
关键词
博尔宁胶囊
硫酸吗啡缓释片
癌性疼痛
Boerning capsules
Morphine sulfate sustained-release tablets
Cancer pain